LUMIFIL KISS with Lidocaine

LUMIFIL

Dermal filler

Cross-linked hyaluronic acid lip and facial volumising filler with lidocaine

The LUMIFIL range is CE marked as a Class III medical device within the EU, indicating compliance with applicable health, safety and environmental requirements for medical devices.
Manufacturing is carried out under an ISO 13485 Certified quality management system, as referenced in the official LUMIFIL technical product brochure.
HCCL (Highly Completed Cross Linking) technology and controlled BDDE content are emphasised in manufacturer documentation to support safety, stability and low residual cross Linker levels.

The LUMIFIL range is CE marked as a Class III medical device within the EU, indicating compliance with applicable health, safety and environmental requirements for medical devices.
Manufacturing is carried out under an ISO 13485 Certified quality management system, as referenced in the official LUMIFIL technical product brochure.
HCCL (Highly Completed Cross Linking) technology and controlled BDDE content are emphasised in manufacturer documentation to support safety, stability and low residual cross Linker levels.
Practitioners should verify current CE / UKCA status, device classification and any national registrations by checking the physical product labelling and relevant regulatory databases before clinical use or marketing.

Description

LUMIFIL KISS with Lidocaine is a cross-linked hyaluronic acid (HA) dermal filler specifically designed for lip augmentation and for areas requiring a thicker, higher-viscosity gel such as the cheeks, chin, jawline and nasolabial folds. The product forms part of the LUMIFIL family of premium HA fillers produced using HCCL (Highly Completed Cross-Linking) technology to create a stable 3D matrix with high viscoelasticity, uniform particle size and low residual BDDE. Each pre-filled syringe contains 1 ml of 20 mg/ml cross-linked HA with 0.3% lidocaine to enhance patient comfort during injection. KISS is positioned as the higher-viscosity option in the range, providing strong volumising power and natural yet full results in dynamic areas like the lips, with typical longevity quoted around 9–12 months and, by some distributors, up to approximately 12–15 months depending on individual factors and treatment technique.

Bnefits

Ideal HA dermal filler for lip augmentation, providing full, well-defined volume with a natural-looking finish.
Thicker, higher-viscosity gel suitable for dynamic areas and deeper folds (cheeks, chin, jawline, nasolabial folds) where stronger structural support is required.
Cross-linked hyaluronic acid 20 mg/ml designed to deliver long-lasting volume and contouring.
Contains 0.3% lidocaine to reduce discomfort and improve patient tolerance during injection.
High viscoelasticity so the gel maintains shape and projection while adapting to facial movement.
Patented particle technology and uniform particle size, supporting smooth extrusion, moulding and predictable results.
High quality and density (around 2,500,000 Da particle weight reported for the LUMIFIL range) contributing to durable volumising effect.
Designed via HCCL cross-linking technology to optimise cohesivity, elasticity and plasticity for safe, stable performance.
Clinically evaluated as part of the LUMIFIL family, with trials demonstrating safety and efficacy for nasolabial fold correction compared to a reference HA device.
Provides long-lasting correction, with distributors typically citing approximately 9–12 months, and in some listings around 12–15 months, depending on area treated, injection technique and individual metabolism.